Acorda Therapeutics, Inc. short interest in 2020
In 2020, Acorda Therapeutics, Inc.'s disclosed short interest ran from 29.47% of shares outstanding on 15 Jan 2020 to 17.35% on 30 Nov 2020, a change of -12.12 percentage points. The year's high was 30.75% on 14 Feb 2020 and its low 11.29% on 13 Nov 2020, averaging 23.12% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.26 days on 15 Apr 2020. Full history: Acorda Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2020 in figures
- Start of year
- 29.47% (15 Jan 2020)
- End of year
- 17.35% (30 Nov 2020)
- Change
- -12.12 pp
- High
- 30.75% (14 Feb 2020)
- Low
- 11.29% (13 Nov 2020)
- Average
- 23.12%
- Highest days to cover
- 14.26 (15 Apr 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 29.47% | 3.82 | results (8-K) |
| 31 Jan 2020 | 30.36% | 5.75 | |
| 14 Feb 2020 | 30.75% | 9.12 | results (8-K) |
| 28 Feb 2020 | 29.28% | 6.40 | 10-K filed |
| 13 Mar 2020 | 29.03% | 11.98 | |
| 31 Mar 2020 | 27.66% | 12.26 | |
| 15 Apr 2020 | 27.25% | 14.26 | |
| 30 Apr 2020 | 29.55% | 12.19 | |
| 15 May 2020 | 21.62% | 3.58 | results (8-K), 10-Q filed |
| 29 May 2020 | 17.48% | 5.10 | |
| 15 Jun 2020 | 21.66% | 3.59 | |
| 30 Jun 2020 | 19.01% | 5.02 | |
| 15 Jul 2020 | 19.98% | 6.30 | |
| 31 Jul 2020 | 20.47% | 3.54 | |
| 14 Aug 2020 | 20.89% | 4.34 | results (8-K), 10-Q filed |
| 31 Aug 2020 | 22.92% | 8.14 | |
| 15 Sep 2020 | 21.03% | 8.58 | |
| 30 Sep 2020 | 26.27% | 1.08 | |
| 15 Oct 2020 | 20.14% | 3.44 | |
| 30 Oct 2020 | 15.09% | 1.00 | |
| 13 Nov 2020 | 11.29% | 1.43 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 17.35% | 3.52 |
See also: Acorda Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.